论文部分内容阅读
今年3月6～20日国家计划生育委员会赴日考察组一行5人在日本家族计划国际协力财团(Joi-cfp)的热情接待和周密安排下参观了6所医院的妇产科及80年竣工的综合母子保健中心,访问了一个药品研究所重点了解前列腺素E_1诱发剂O_(no)823的试制过程,包括动物实验及临床效果,证实O_(no)802对子宫平滑肌作用的特异性,因此该药除引起子宫收缩外,类似其它前列腺素的副作用很低或是没有,而且功效持续时间较长,但现在还处于临床试用阶段。此外,还参观了二个工厂,一是质量居于世界首位的避孕套制造厂;一是阴道用杀精子泡
From March 6 to March 20, the delegation of 5 members of the State Family Planning Commission’s delegation to Japan visited the obstetrics and gynecology department of the six hospitals and completed their 80-year mission under the enthusiastic reception and careful arrangement of the Joi-cfp Japanese Family Planning Association Comprehensive Mother-and-Child Healthcare Center visited a pharmaceutical institute to focus on the trial production of prostaglandin E 1 -induced O_ (no) 823, including animal experiments and clinical effects, confirming the specificity of O_ (no) 802 for uterine smooth muscle function. In addition to causing the uterus contraction of the drug, similar to other prostaglandins with little or no side effects, and longer duration of efficacy, but is still in clinical trial stage. In addition, visited two factories, one condom factory with the highest quality in the world; one is vaginal spermicidal bubble